< Back to scientific publications

Magazine 11.50

Clinical experience with intravenous valproate as first-line treatment of status epilepticus and seizure clusters in selected populations.

Authors: Lapenta L, Morano A, Casciato S, Fanella M, Fattouch J, Vaudano AE, Gregori B, Vanacore N, Manfredi M, Giallonardo AT, Di Bonaventura C.

Date: 2014

Scope of interest: Epilepsy




You may also be interested in:

Report/Poster of Convention/Congress Act

Rapid paroxysmal generalized activity in NREM sleep: prognostic significance in idiopathic generalized epilepsies.

Authors: Fattouch J, Di Bonaventura C, Lapenta L, Casciato S, Fanella M, Morano A, Manfredi M, Berardelli A, Giallonardo AT

Date: 2012

Scope of interest: Epilepsy


Read details
Magazine 4.3

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients.

Authors: Pellicelli A et al

Date: May 20

Scope of interest: infectious/hepatological


Read details
Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy


Read details